Published in J Immunol on August 14, 2009
Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nat Rev Immunol (2010) 3.56
Adenosine production by human B cells and B cell-mediated suppression of activated T cells. Blood (2013) 1.70
Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells. Sci Transl Med (2011) 1.56
Regulatory T-cell therapy in transplantation: moving to the clinic. Cold Spring Harb Perspect Med (2013) 1.29
Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation. Am J Transplant (2013) 1.14
Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein. Eur J Immunol (2010) 1.13
TIM-3: a novel regulatory molecule of alloimmune activation. J Immunol (2010) 1.05
Exploiting antitumor immunity to overcome relapse and improve remission duration. Cancer Immunol Immunother (2011) 1.04
The paradoxical functions of B cells and antibodies in transplantation. J Immunol (2013) 0.92
Promoting transplantation tolerance; adoptive regulatory T cell therapy. Clin Exp Immunol (2013) 0.88
Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation. Front Immunol (2015) 0.87
Comparative study of regulatory T cells expanded ex vivo from cord blood and adult peripheral blood. Immunology (2012) 0.86
Regulatory cells and transplantation tolerance. Cold Spring Harb Perspect Med (2013) 0.86
Potential impact of B cells on T cell function in multiple sclerosis. Mult Scler Int (2011) 0.85
Update on the immunological pathway of negative regulation in acute insults and sepsis. J Interferon Cytokine Res (2012) 0.81
B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms. Biologics (2012) 0.79
Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients. Am J Transplant (2015) 0.77
Regulatory T-cell immunotherapy for allogeneic hematopoietic stem-cell transplantation. Ther Adv Hematol (2012) 0.77
BAFF promotes regulatory T-cell apoptosis and blocks cytokine production by activating B cells in primary biliary cirrhosis. Braz J Med Biol Res (2013) 0.77
IL-10-Producing CD1d(hi)CD5(+) Regulatory B Cells May Play a Critical Role in Modulating Immune Homeostasis in Silicosis Patients. Front Immunol (2017) 0.75
Tolerance in liver transplantation: Biomarkers and clinical relevance. World J Gastroenterol (2016) 0.75
Regulatory T cells: Tolerance Induction in Solid Organ Transplantation. Clin Exp Immunol (2017) 0.75
B Cell Requirement for Robust Regulatory T Cell Responses to Friend Retrovirus Infection. MBio (2017) 0.75
CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses. Nat Immunol (2002) 2.40
CORRELATION OF OPTICAL INTENSITY ON OPTICAL COHERENCE TOMOGRAPHY AND VISUAL OUTCOME IN CENTRAL RETINAL ARTERY OCCLUSION. Retina (2016) 1.95
Memory CD8+ T cells provide an early source of IFN-gamma. J Immunol (2003) 1.93
Constitutive nuclear localization of NFAT in Foxp3+ regulatory T cells independent of calcineurin activity. J Immunol (2012) 1.51
Transcriptional regulation of the MHC class II antigen presentation pathway. Curr Opin Immunol (2003) 1.48
Epistasis between microRNAs 155 and 146a during T cell-mediated antitumor immunity. Cell Rep (2012) 1.46
Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells. J Immunol (2010) 1.46
Mice completely lacking immunoproteasomes show major changes in antigen presentation. Nat Immunol (2011) 1.45
Prognostic factors and risk stratification in early mycosis fungoides. Leuk Lymphoma (2013) 1.42
Interstitial myocardial fibrosis assessed as extracellular volume fraction with low-radiation-dose cardiac CT. Radiology (2012) 1.27
Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2. J Immunol (2003) 1.22
A community-based tuberculosis program in Cambodia. JAMA (2004) 1.21
Fingerprint recognition with identical twin fingerprints. PLoS One (2012) 1.16
A potent vaccination strategy that circumvents lymphodepletion for effective antitumor adoptive T-cell therapy. Cancer Res (2012) 1.14
Automatic renal cortex segmentation using implicit shape registration and novel multiple surfaces graph search. IEEE Trans Med Imaging (2012) 1.12
NK cells stimulate proliferation of T and NK cells through 2B4/CD48 interactions. J Immunol (2004) 1.11
Cutting edge: HLA-DM functions through a mechanism that does not require specific conserved hydrogen bonds in class II MHC-peptide complexes. J Immunol (2009) 1.10
Exploiting antitumor immunity to overcome relapse and improve remission duration. Cancer Immunol Immunother (2011) 1.04
Severe liver and skin toxicity after radiation and vemurafenib in metastatic melanoma. J Clin Oncol (2013) 1.03
Cutting edge: primary B lymphocytes preferentially expand allogeneic FoxP3+ CD4 T cells. J Immunol (2007) 1.02
Synthesis and phosphodiesterase 5 inhibitory activity of novel pyrido[1,2-e]purin-4(3H)-one derivatives. Bioorg Med Chem Lett (2005) 1.02
Joint segmentation of anatomical and functional images: applications in quantification of lesions from PET, PET-CT, MRI-PET, and MRI-PET-CT images. Med Image Anal (2013) 1.02
Hierarchical scale-based multiobject recognition of 3-D anatomical structures. IEEE Trans Med Imaging (2011) 1.01
Regulated expression of human histocompatibility leukocyte antigen (HLA)-DO during antigen-dependent and antigen-independent phases of B cell development. J Exp Med (2002) 1.00
Positive selection of a Qa-1-restricted T cell receptor with specificity for insulin. Immunity (2002) 1.00
Predicting future morphological changes of lesions from radiotracer uptake in 18F-FDG-PET images. PLoS One (2013) 0.99
Regulation of HLA-DR peptide occupancy by histone deacetylase inhibitors. Hum Vaccin Immunother (2013) 0.98
Automated 3-D retinal layer segmentation of macular optical coherence tomography images with serous pigment epithelial detachments. IEEE Trans Med Imaging (2014) 0.98
Large scale mass spectrometric profiling of peptides eluted from HLA molecules reveals N-terminal-extended peptide motifs. J Immunol (2008) 0.96
Peptide-independent folding and CD8 alpha alpha binding by the nonclassical class I molecule, thymic leukemia antigen. J Immunol (2002) 0.96
The role of B lymphocytes as antigen-presenting cells. Arch Immunol Ther Exp (Warsz) (2008) 0.96
MHC class II antigen presentation and immunological abnormalities due to deficiency of MHC class II and its associated genes. Exp Mol Pathol (2008) 0.95
Functional characterization of a wheat plasma membrane Na+/H+ antiporter in yeast. Arch Biochem Biophys (2008) 0.95
Evidence for antibody-mediated enhancement of simian immunodeficiency virus (SIV) Gag antigen processing and cross presentation in SIV-infected rhesus macaques. J Virol (2003) 0.94
An MHC class Ib-restricted CD8 T cell response confers antiviral immunity. J Exp Med (2008) 0.94
Differential miRNA expression in Rehmannia glutinosa plants subjected to continuous cropping. BMC Plant Biol (2011) 0.94
Utility of virtual crossmatch in sensitized patients awaiting heart transplantation. J Heart Lung Transplant (2009) 0.93
H2-O expression in primary dendritic cells. J Immunol (2006) 0.92
Renal cortex segmentation using optimal surface search with novel graph construction. Med Image Comput Comput Assist Interv (2011) 0.92
ERAAP and tapasin independently edit the amino and carboxyl termini of MHC class I peptides. J Immunol (2013) 0.90
Random Walk and Graph Cut for Co-Segmentation of Lung Tumor on PET-CT Images. IEEE Trans Image Process (2015) 0.89
The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes. J Immunol (2004) 0.88
Penaeus monodon tropomyosin induces CD4 T-cell proliferation in shrimp-allergic patients. Hum Immunol (2011) 0.88
Modification of peptide interaction with MHC creates TCR partial agonists. Cell Immunol (2004) 0.88
Lysosomal β-glucuronidase regulates Lyme and rheumatoid arthritis severity. J Clin Invest (2013) 0.87
Immunodeficiency and autoimmunity in H2-O-deficient mice. J Immunol (2012) 0.87
Utility of characteristic QTOF MS/MS fragmentation for MHC class I peptides. J Proteome Res (2011) 0.87
The expression of HLA-DO (H2-O) in B lymphocytes. Immunol Res (2004) 0.87
Effect of decreasing the affinity of the class II-associated invariant chain peptide on the MHC class II peptide repertoire in the presence or absence of H-2M. J Immunol (2004) 0.86
Increased FasL expression correlates with apoptotic changes in granulocytes cultured with oxidized clozapine. Toxicol Appl Pharmacol (2006) 0.86
Identification of naturally processed ligands in the C57BL/6 mouse using large-scale mass spectrometric peptide sequencing and bioinformatics prediction. Immunogenetics (2009) 0.85
Identification and validation of shrimp-tropomyosin specific CD4 T cell epitopes. Hum Immunol (2013) 0.84
Higher SLPI expression, lower immune activation, and increased frequency of immune cells in a cohort of Colombian HIV-1 controllers. J Acquir Immune Defic Syndr (2012) 0.83
Homeostatic proliferation of a Qa-1b-restricted T cell: a distinction between the ligands required for positive selection and for proliferation in lymphopenic hosts. J Immunol (2004) 0.82
Class II transactivator is required for maximal expression of HLA-DOB in B cells. J Immunol (2002) 0.82
Validation of cytomegalovirus immune competence assays for the characterization of CD8(+) T cell responses posttransplant. Clin Dev Immunol (2012) 0.81
Automatic Liver Segmentation Based on Shape Constraints and Deformable Graph Cut in CT Images. IEEE Trans Image Process (2015) 0.81
Polyclonal MHC Ib-restricted CD8+ T cells undergo homeostatic expansion in the absence of conventional MHC-restricted T cells. J Immunol (2008) 0.81
Differential requirement for tapasin in the presentation of leader- and insulin-derived peptide antigens to Qa-1b-restricted CTLs. J Immunol (2004) 0.80
Structural Characteristics of HLA-DQ that May Impact DM Editing and Susceptibility to Type-1 Diabetes. Front Immunol (2013) 0.80
Specificity of EIA immunoassay for complement factor Bb testing. Clin Lab (2011) 0.80
MicroRNA-146a constrains multiple parameters of intestinal immunity and increases susceptibility to DSS colitis. Oncotarget (2015) 0.79
A novel single chain I-A(b) molecule can stimulate and stain antigen-specific T cells. Mol Immunol (2003) 0.79
Binding of anti-HLA class I antibody to endothelial cells produce an inflammatory cytokine secretory pattern. J Clin Lab Anal (2009) 0.79
Development and validation of a fluorescent microsphere immunoassay for soluble CD30 testing. Clin Vaccine Immunol (2009) 0.79
Hippocampal N-acetylaspartate and morning cortisol levels in drug-naive, first-episode patients with major depressive disorder: effects of treatment. J Psychopharmacol (2012) 0.78
An MHC class Ib-restricted CD8+ T cell response to lymphocytic choriomeningitis virus. J Immunol (2011) 0.78
In vivo quantification of pulmonary inflammation in relation to emphysema severity via partial volume corrected (18)F-FDG-PET using computer-assisted analysis of diagnostic chest CT. Hell J Nucl Med (2013) 0.78
Composite patient reports: a laboratory informatics perspective and pilot project for personalized medicine and translational research. Summit on Translat Bioinforma (2009) 0.77
Reference interval computation: which method (not) to choose? Clin Chim Acta (2012) 0.77
Resampling approach for determination of the method for reference interval calculation in clinical laboratory practice. Clin Vaccine Immunol (2010) 0.76
Fetal-maternal HLA-A and -B discordance is associated with placental RNase expression and anti-HIV-1 activity. Curr HIV Res (2008) 0.76
Dendritic cells: caspases keep them young. Nat Immunol (2005) 0.76
Cat and mouse. Nat Immunol (2008) 0.75
High soluble CD30, CD25, and IL-6 may identify patients with worse survival in CD30+ cutaneous lymphomas and early mycosis fungoides. J Invest Dermatol (2011) 0.75
A flattest constrained envelope approach for empirical mode decomposition. PLoS One (2013) 0.75
Trimming creates a new self-image. Nat Immunol (2007) 0.75
All peptide-MHC complexes are not created equal. Nat Immunol (2002) 0.75
Fine mapping of the Bmgr5 quantitative trait locus for allogeneic bone marrow engraftment in mice. Immunogenetics (2013) 0.75
Multi-Scale Rotation-Invariant Convolutional Neural Networks for Lung Texture Classification. IEEE J Biomed Health Inform (2017) 0.75
Subacute hepatic necrosis mimicking veno-occlusive disease in a patient with HFE H63D homozygosity after allogeneic hematopoietic cell transplantation with busulfan conditioning. Int J Hematol (2015) 0.75
HLA-DO. A useful marker to distinguish florid follicular hyperplasia from follicular lymphoma by flow cytometry. Am J Clin Pathol (2003) 0.75
Choroid Neovascularization Growth Prediction with Treatment Based on Reaction-Diffusion Model in 3D OCT Images. IEEE J Biomed Health Inform (2017) 0.75
3D Fast Automatic Segmentation of Kidney Based on Modified AAM and Random Forest. IEEE Trans Med Imaging (2016) 0.75
Optic Disk Detection in Fundus Image Based on Structured Learning. IEEE J Biomed Health Inform (2017) 0.75
[Construction and analysis of suppression subtractive cDNA libraries of continuous monoculture Rehmannia glutinosa]. Zhongguo Zhong Yao Za Zhi (2011) 0.75
Urine TGF- beta1 assay validation: spinning down urine samples could diminish TGF-beta1 signal. Clin Lab (2011) 0.75
A spectrophotometric method to precisely determine endpoint titers in complement fixation assays. J Clin Lab Anal (2012) 0.75
Liposomes composed of reconstituted membranes for induction of tumor-specific immunity. Methods Enzymol (2003) 0.75
An MHC class Ib-restricted TCR that cross-reacts with an MHC class Ia molecule. J Immunol (2005) 0.75
Resampling model of the complement component functional assay: Are we measuring what we think we are measuring? Clin Chim Acta (2013) 0.75
[Studies on immunocompetent constituents of Patrinia scabra Bunge]. Zhong Yao Cai (2002) 0.75
[Effects of leaf removal on growth and physiological characteristics of Rehmannia glutinosa]. Zhongguo Zhong Yao Za Zhi (2011) 0.75